The cure of cancer: A European perspective

Francisci, Silvia; Capocaccia, Riccardo; Grande, Enrico; Santaquilani, Mariano; Simonetti, A; Allemani, Claudia; Gatta, Gemma; Sant, Milena; Zigon, Giulia; Bray, Freddie; Janssen‐Heijnen, M.L.G.

doi:10.1016/j.ejca.2008.11.034

Cited by 82 publications

(81 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The proportion of cured patients indicator has been estimated by EUROCARE for all cancers combined and various cancer sites for several European countries. 4 It is also useful to identify other sub-groups of prevalent cases according to their clinical situation and likely demands on health care facilities. To do this, cancer registry data (incidence and vital status) are combined with information on treatment (or use of health service facilities) and follow-up (to identify recurrences, metastases, second tumours, side-effects of treatment, etc.)…”

Section: Indicators On Cancer Rehabilitation Needsmentioning

confidence: 99%

“…3 EUROCARE estimated that the proportion of patients (diagnosed from 1988 to 1999) considered cured of their cancer (all cancers combined) varied between 38% and 59% in women, and 21% and 47% in men, by country. 4 Cancer is often a chronic condition and patients may endure physical and psychological symptoms for years after their treatment is complete. 5 Such symptoms can worsen the quality of life, and include pain, fatigue, cognitive impairment, worries about health, irritable mood, demoralization, depression and interpersonal problems.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Cancer rehabilitation indicators for Europe

Baili

Hoekstra-Weebers²,

Hoof

et al. 2013

European Journal of Cancer

View full text Add to dashboard Cite

Little is known of cancer rehabilitation needs in Europe. EUROCHIP-3 organised a group of experts to propose a list of population-based indicators used for describing cancer rehabilitation across Europe. The aim of this study is to present and discuss these indicators. A EUROCHIP-3 expert panel reached agreement on two types of indicators. (a) Cancer prevalence indicators. These were proposed as a means of characterising the burden of cancer rehabilitation needs by time from diagnosis and patient health status. These indicators can be estimated from cancer registry data or by collecting data on follow-up and treatments for samples of cases archived in cancer registries. (b) Indicators of rehabilitation success. These include: return to work, quality of life, and satisfaction of specific rehabilitation needs. Studies can be performed to estimate these indicators in individual countries, but to obtain comparable data across European countries it will be necessary to administer a questionnaire to randomly selected samples of patients from population-based cancer registry databases. However, three factors complicate questionnaire studies: patients may not be aware that they have cancer; incomplete participation in surveys could lead to bias; and national confidentiality laws in some cases prohibit cancer registries from approaching patients. Although these studies are expensive and difficult to perform, but as the number of cancer survivors increases, it is important to document their needs in order to provide information on cancer control.

show abstract

Section: Indicators On Cancer Rehabilitation Needsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Cancer rehabilitation indicators for Europe

Baili

Hoekstra-Weebers²,

Hoof

et al. 2013

European Journal of Cancer

View full text Add to dashboard Cite

show abstract

“…In particular, breast cancer is the most prevalent tumor in females (Capocaccia et al, 2015;Dal Maso et al, 2014). This prevalence is steadily increasing due to screening strategies which allow to recognize early stages of disease (Francisci et al, 2009). …”

Section: Introductionmentioning

confidence: 99%

Active lifestyle promotion with home-based exercise in breast cancer survivors

Mascherini

Giannelli

Ghelarducci

et al. 2017

jhse

View full text Add to dashboard Cite

Background: In cancer survivors, quality of life, weight management and physical activity levels are growing areas of interest, also considering such parameters may offer protection to cancer recurrence. Research question: In this study, we aimed to objectively verify whether a home-based exercise program is effective in weight management of a cohort of breast-cancer survivors. Type of study: Experimental cohort observational study. Methods: We enrolled 13 women (age 49.1±5.5, height 163±7.3 cm) and evaluated habitual physical activity levels. Afterwards we compared the baseline aerobic capacity by 6 Minutes Walking Test (6MWT), flexibility, grip and lower limbs strength and body composition, to the same parameters measured after 40 days of unsupervised exercise. Results: At baseline (T0), patients displayed a moderate level of physical activity and were overweight. After 40 days of unsupervised exercise (T1), we observed improvement of all analyzed parameters with statistical significance in waist circumference (T0=0.57±0.1 cm, T1=0.55±0.1 cm; p<0.01), distance walked in 6 MWT (T0445.4±168.1 m, T1=534.6±151.5 m; p<0.05), 30 '' Chair test (T0=14.8±5.6 rep, T1=16.3±4.9 rep; p<0.05). Conclusions: Home-based unsupervised exercise in breastcancer survivors yielded short-term efficacy in all analyzed parameters. Efficacy at long -term and a possible effect in reducing the risk of tumor relapse remain to be elucidated in larger cohorts with longer and multidisciplinary follow up.

show abstract

“…Accurate statistics on the cancer burden are essential, both for purposes of research and for defining setting priorities in healthcare management and planning cancer control programs (Parkin, 2006). Thus, these are necessary for epidemiological measures to defining preferences and allocate resources (Francisci et al, 2009). …”

Section: Introductionmentioning

confidence: 99%

Estimation of the Projections of the Incidence Rates, Mortality and Prevalence Due to Common Cancer Site in Isfahan, Iran

Moradpour

Fatemi²

2013

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

Background: Accurate statistics on the cancer burden are essential, both for purposes of research and for setting priorities in healthcare management. So that in vast countries with partial registration coverage, such as Iran, local data are more useful. We here estimated the incidence, prevalence and mortality time trend of four major cancer site, lung, stomach, breast and prostate, over the period 2001-2010 and provided short-range projections to 2015 in Isfahan. Materials and Methods: Estimates were derived by applying the mortality-incidence analysis method, a back-calculation approach to estimate and project incidence, prevalence and mortality of chronic degenerative disease, starting from knowledge of mortality and relative survival information. Results: Age adjusted incidence, mortality and prevalence rates in Isfahan exhibited a clear upward trend for all four sites during the period 2001-2015, with marked increasees in prostate and breast predicted for the future. Difference in incidence trends between males and females might be attributable to the difference in risk factors specific to certain cancer sites, with smoking being the main risk factor. Conclusions: In this study, males and females displayed an increasing pattern for incidence and mortality rate over the entire study period until 2015. This information can be used as basis for planning healthcare management and allocating recourses in public health.

show abstract

The cure of cancer: A European perspective

Cited by 82 publications

References 29 publications

Cancer rehabilitation indicators for Europe

Cancer rehabilitation indicators for Europe

Active lifestyle promotion with home-based exercise in breast cancer survivors

Estimation of the Projections of the Incidence Rates, Mortality and Prevalence Due to Common Cancer Site in Isfahan, Iran

Contact Info

Product

Resources

About